• FirefoxInstall the new Firefox »
  •  Dow Down 0.56% Nasdaq Down 0.73%

    Geron Corporation (GERN)

    -NasdaqGS
    2.95 Down 0.08(2.48%) 1:55PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.02
    Open:3.00
    Bid:2.93 x 9400
    Ask:2.94 x 10900
    1y Target Est:4.63
    Beta:2.44
    Next Earnings Date: 3-Mar-15GERN Earnings announcement
    Day's Range:2.93 - 3.02
    52wk Range:1.31 - 4.62
    Volume:1,381,559
    Avg Vol (3m):2,802,830
    Market Cap:462.99M
    P/E (ttm):N/A
    EPS (ttm):-0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GERNDown 2.48%462.99M
    BMYDown 0.95%102.57B
    GSKDown 0.70%114.49B
    NVSDown 0.96%237.72B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):395.65
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.12
    Quarterly EPS Est (Dec-14) :0.05
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-5.25

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback